Table 3.
Logistic regression for variables predictive of clozapine response
| Variable | Research setting (n = 85)
 | 
Routine clinical practice (n = 223)
 | 
||||||
|---|---|---|---|---|---|---|---|---|
| Odds Ratio | 95% CI | χ2 (df = 1) | P-value | Odds ratio | 95% CI | χ2 (df = 1) | P-value | |
| Age (Years) | 0.90 | 0.82–0.99 | 4.28 | 0.04a | 0.99 | 0.95–1.04 | 0.08 | 0.77 | 
| Race: White | 1.80 | 0.41–7.88 | 0.6 | 0.44 | 1.00 | 0.49–2.05 | < 0.001 | 0.99 | 
| Male | 0.23 | 0.06–0.92 | 4.33 | 0.04b | 1.48 | 0.64–3.42 | 0.82 | 0.37 | 
| Baseline positive symptoms | 0.91 | 0.74–1.13 | 0.71 | 0.40 | 1.00 | 0.91–1.09 | 0.01 | 0.92 | 
| Baseline negative symptoms | 0.63 | 0.23–1.74 | 0.81 | 0.41 | 0.95 | 0.70–1.29 | 0.12 | 0.99 | 
| Baseline hostility | 1.15 | 0.90–1.47 | 1.17 | 0.28 | 0.99 | 0.86–1.10 | 0.07 | 0.79 | 
| Baseline anxiety/Depression | 0.87 | 0.72–1.05 | 2.19 | 0.14 | 1.04 | 0.96–1.14 | 0.91 | 0.34 | 
| Baseline activation | 0.90 | 0.67–1.19 | 0.57 | 0.45 | 0.90 | 0.81–1.00 | 3.56 | 0.06c | 
Younger patients more likely to respond
Females more likely to respond
Trend for higher activation scores more likely to respond